Clive Mulatero

Leeds, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy.

Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy.

Journal: British journal of cancer

Published: June 21, 2024

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: March 14, 2022

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial.

Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial.

Journal: Oncoimmunology

Published: September 06, 2017

Ipilimumab-induced colitis: experience from a tertiary referral center.

Ipilimumab-induced colitis: experience from a tertiary referral center.

Journal: Therapeutic advances in gastroenterology

Published: July 02, 2016

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.

Outcome and Biomarker Analysis from a Multicenter Phase 2 Study of Ipilimumab in Combination with Carboplatin and Etoposide as First-Line Therapy for Extensive-Stage SCLC.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: April 25, 2016

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK.

Expert Consensus on the Management of Adverse Events from EGFR Tyrosine Kinase Inhibitors in the UK.

Journal: Drugs

Published: July 19, 2015

Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma.

Prevalence and correlates of unmet supportive care needs in patients with resected invasive cutaneous melanoma.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: August 02, 2014

A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer.

A phase Ib dose-escalation study of everolimus combined with cisplatin and etoposide as first-line therapy in patients with extensive-stage small-cell lung cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: December 26, 2013

Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours.

Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours.

Journal: Health technology assessment (Winchester, England)

Published: July 23, 2013

Mutation detection by clonal sequencing of PCR amplicons and grouped read typing is applicable to clinical diagnostics.

Mutation detection by clonal sequencing of PCR amplicons and grouped read typing is applicable to clinical diagnostics.

Journal: Human mutation

Published: May 11, 2012

Denosumab for treatment of bone metastases secondary to solid tumours: systematic review and network meta-analysis.

Denosumab for treatment of bone metastases secondary to solid tumours: systematic review and network meta-analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 03, 2012

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) masquerading as metastatic carcinoma with multiple pulmonary deposits.

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) masquerading as metastatic carcinoma with multiple pulmonary deposits.

Journal: Clinical imaging

Published: November 14, 2011

Showing 1-12 of 12

Last Updated: 09/26/2026